Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-refractory Bronchiolitis Obliterans”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)UnknownNCT04189432
What this trial is testing

Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host-disease
SCM Lifescience Co., LTD. 84
Testing effectiveness (Phase 2)Ended earlyNCT04200365
What this trial is testing

Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)Study completedNCT02997280
What this trial is testing

Ruxolitinib for Steroid-refractory GVHD

Who this might be right for
Graft Vs Host Disease
St. Petersburg State Pavlov Medical University 75
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Testing effectiveness (Phase 2)Ended earlyNCT04232397
What this trial is testing

Anlotinib Treatment in Steroid Depenent/Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5
Early research (Phase 1)Looking for participantsNCT06991361
What this trial is testing

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

Who this might be right for
Graft Versus Host Disease (cGvHD)
Leslie Kean 21
Not applicableEnded earlyNCT04852692
What this trial is testing

Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Who this might be right for
Chronic Graft vs Host Disease
Janssen Korea, Ltd., Korea 15
Testing effectiveness (Phase 2)Ended earlyNCT01226420
What this trial is testing

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 6
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Very early researchLooking for participantsNCT06920199
What this trial is testing

Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2

Who this might be right for
cGVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 18
Early research (Phase 1)Active Not RecruitingNCT01937468
What this trial is testing

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft Versus Host DiseaseChronic GVHDComplications of Organ Transplant Stem Cells
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT01810718
What this trial is testing

Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft Versus Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 22
Testing effectiveness (Phase 2)Study completedNCT01954979
What this trial is testing

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Beth Israel Deaconess Medical Center 56
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Testing effectiveness (Phase 2)UnknownNCT01639261
What this trial is testing

A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT

Who this might be right for
Steroid-refractory Bronchiolitis Obliterans
University Hospital Regensburg 10
Large-scale testing (Phase 3)Study completedNCT03112603
What this trial is testing

Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 330
Testing effectiveness (Phase 2)UnknownNCT00472225
What this trial is testing

Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Steroid-Refractory Chronic GVHD
The Korean Society of Hematopoietic Stem Cell Transplantation 42
Early research (Phase 1)Study completedNCT00529035
What this trial is testing

Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 29
Testing effectiveness (Phase 2)Study completedNCT02340676
What this trial is testing

A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT03007238
What this trial is testing

Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
City of Hope Medical Center 10
Next Page